Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma.
case_control · Level III
Where this comes from
- Record sourced from PubMed, PMID 22294418.
- Also identified by DOI 10.1002/hed.21810 and PMC identifier 3323768.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Head and neck squamous cell carcinoma (HNSCC) is a devastating disease usually diagnosed at a late stage when cure rates are 40%. We examined a simple and inexpensive molecular tool that may aid HNSCC detection. Building on prior findings that total protein levels are elevated in 102 HNSCC cases versus 84 control subjects, we further analyzed these levels with respect to important risk and demographic variables and compared the results to soluble CD44 (solCD44). Using multivariate adaptive regression splines (MARSs)-logit modeling and logistic regression, we determined whether total protein, solCD44, or the combination best identifies HNSCC. Combined higher levels of solCD44 and protein were significantly associated with HNSCC (odds ratio [OR] = 24.90; 95% confidence interval [CI], 9.04-68.57; area under the curve [AUC] = 0.786). A model including protein plus solCD44 resulted in a better area (AUC 0.796) than either marker alone. Oral rinse levels of solCD44 and protein seem to hold promise for detection of HNSCC.
Medical subject headings
- Carcinoma, Squamous Cell
- Early Diagnosis
- Head and Neck Neoplasms
- Hyaluronan Receptors